Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on expression of 3...
Salvato in:
Autori principali: | , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | inglese |
Pubblicazione: |
2018
|
Accesso online: | https://doi.org/10.1186/s13000-018-0690-3 https://diagnosticpathology.biomedcentral.com/track/pdf/10.1186/s13000-018-0690-3 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|